David Walsey joined Bay Area Lyme Foundation as Executive Director in 2025. He is a
strategic biotech leader with 25 years of experience advancing corporate objectives
through strategy, communications, financing, and investor initiatives for public
companies. Most recently, David served as Senior Vice President, Corporate Affairs at
MEI Pharma, leading programs spanning corporate strategy, investor relations, and
corporate communications. He previously held senior roles at Alder Biopharmaceuticals,
Optimer Pharmaceuticals, Sarepta Therapeutics (formerly AVI BioPharma), Arena
Pharmaceuticals, and Maxim Pharmaceuticals, and worked at agencies including Real
Chemistry (formerly W20 Group), The Ruth Group, and Noonan Russo. He began his
career as an attorney in private practice in New York City and holds an LL.M. in Taxation
from New York University School of Law, a J.D. from Brooklyn Law School, and a B.A.
from Franklin and Marshall College.
